Allianz Asset Management
BDSI

Allianz Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Allianz Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-805,920
Closed -$8.46M – 2633
2015
Q1 		$8.46M Buy
805,920
+12,000
+2% +$164K 0.01% 1020
2014
Q4 		$9.54M Buy
793,920
+313,960
+65% +$4.77M 0.01% 971
2014
Q3 		$8.2M Buy
479,960
+133,000
+38% +$1.93M 0.01% 906
2014
Q2 		$4.19M Sell
346,960
-35,830
-9% -$340K 0.01% 979
2014
Q1 		$3.23M Hold
382,790
– – ﹤0.01% 1067
2013
Q4 		$2.25M Buy
382,790
+148,835
+64% +$767K ﹤0.01% 1177
2013
Q3 		$1.27M Buy
+233,955
New +$1.12M ﹤0.01% 1316

Other funds holding BDSI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Allianz Asset Management's BDSI Position: Q2 2015 in Review

Allianz Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2015, closing a stake of 805,920 shares — an estimated $8.46M sold.

Allianz Asset Management first reported a position in BDSI in Q3 2013 and held it in 7 quarters. The position peaked at $9.54M in Q4 2014. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2015.

  • Allianz Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2015 after selling out during the quarter.
  • Allianz Asset Management sold 805,920 BioDelivery Sciences International, Inc. shares in Q2 2015, an estimated $8.46M.
  • Allianz Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2013 and held it in 7 quarters.
  • Allianz Asset Management's BioDelivery Sciences International, Inc. position peaked at $9.54M in Q4 2014.
  • 143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2015.

Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.